May 30, 2017
AG 2017 - Présentation de l'Assemblée générale 2017
May 30, 2017
AG 2017 - Résultats des votes de l'Assemblée générale mixte 2017
May 27, 2016
Résultats des votes de l'Assemblée générale mixte 2016
May 26, 2016
Présentation de l'Assemblée générale 2016
June 05, 2015
Résultat des votes - AG 2015
April 29, 2021
AG 2021 - CAC Rapport Résolution n°21
April 29, 2021
AG 2021 - CSE central - Avis - Information - Consultation sur le bilan social consolidé 2020
April 29, 2021
AG 2021 - CAC Rapport Résolutions n°30 et 31
April 29, 2021
AG 2021 - Rapport du Commissaire à la transformation en société européenne
April 29, 2021
AG 2021 - CAC Attestation rémunération
April 15, 2019
2019 - Preliminary notice of meeting to the Ordinary and Extraordinary Shareholders' Meeting of May 23, 2019
April 25, 2018
AG 2018 - Convening notice - Assemblée générale mixte du 17 mai 2018
April 09, 2018
Preliminary notice of meeting to the Ordinary and Extraordinary Shareholders' Meeting of May 17, 2018
May 09, 2017
AG 2017 - Avis de convocation - Assemblée générale du 30 mai 2017
April 24, 2017
Preliminary notice of meeting to the Ordinary and Extraordinary Shareholders' Meeting of May 30, 2017

 

INFORMATION - General Shareholders Meeting 2021

The shareholders of bioMérieux (the “Company”) are hereby invited to attend the Ordinary and Extraordinary Shareholders’ Meeting to be held at 2:00 p.m. (CEST) on May 20, 2021 at 376 Chemin de l’Orme, Marcy l’Etoile (69280), France.

 

IMPORTANT – HEALTH SITUATION

In view of the ongoing health crisis, the Company may have to modify the conditions for participating in the Annual General Meeting of May 20, 2021. Thus, in the event that the conditions set out in Order no. 2020-321 of March 25, 2020 (as amended by Order no. 2020-1497 of December 2, 2020) and Decree No. 2020-418 of April 10, 2020 (as amended by Decree no. 2020-1614 of December 18, 2020), as extended by Decree no. 2021-255 of March 9, 2021, are still met and/or that health conditions so require, the Annual General Meeting may be held behind closed doors.

Consequently, shareholders are encouraged to regularly consult the Company’s website at www.biomerieux.com (Investors > Shareholder Area > General Shareholders’ Meeting), which may be updated to specify the definitive conditions for participating in the Annual General Meeting, depending on health and/or legal requirements.

Furthermore, in view of the circulation of COVID-19 and the government recommendations to avoid public gatherings, the Board of Directors urges the utmost caution and recommends that each shareholder opt to vote by post or by giving proxy to the Chairman rather than attending in person.

The Company has taken all measures to facilitate remote voting so that shareholders may also vote without physically attending the Annual General Meeting, either by using the designated postal voting form available on bioMérieux’s website at www.biomerieux.com (Investors > Shareholder Area > General Shareholders’ Meeting) or by logging on to the VOTACCESS secure voting platform.

Shareholders are asked to send all requests and documents to the following email address: investor.relations@biomerieux.com